according to the cc the license deal is limited to Buprenorphine. Different active ingredients are not part of the deal. So TTNP is free to develop other drugs using the ProNeura technology in any indication they want. Obviously there is much room to use the ProNeura technology with a variety of pain killers. ProNeura has not been given away.